Opioid Use Disorder and Prescribed Opioid Regimens: Evidence from Commercial and Medicaid Claims, 2005-2015.

Mir M Ali¹, Eli Cutler², Ryan Mutter³, Rachel Mosher Henke⁴, Peggy L O'Brien⁴, Jesse M Pines⁵, Maryann Mazer-Amirshahi⁶, Jared Diou-Cass⁷

¹Office of the Assistant Secretary for Planning & Evaluation, US Department of Health & Human Services, 200 Independence Avenue SW, Washington, DC, 20201, USA. ali.mir.m@gmail.com.

²Qventus, Mountain View, CA, USA.

³Health, Retirement and Long-Term Analysis Division, Congressional Budget Office, Washington, DC, USA.

⁴IBM Watson Health, Cambridge, MA, USA.

⁵US Acute Care Solutions, Canton, OH, USA.

⁶MedStar Washington Hospital Center, Washington, DC, USA.

⁷Truven Health Analytics, an IBM company, San Jose, CA, USA.

PubMed PMC DOI PDF

Abstract

INTRODUCTION: In response to the US opioid crisis, interventions are being implemented to lower opioid prescribing to reduce opioid misuse and overdose. As opioid prescribing falls, opioid misuse may shift from prescriptions to other, possibly illicit, sources. We examined how the percentage of patients with an opioid use disorder (OUD) diagnosis in a given year without a current opioid prescripti…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.